Timing of Treatment Completion in Staged Selective Laser Trabeculoplasty (SLT): Early vs. Late Completion
NCT ID: NCT00551395
Last Updated: 2015-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
PHASE3
20 participants
INTERVENTIONAL
2007-09-30
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Is the Reduction in IOP After Treatment of 180 Degrees Equivalent to Treatment of 360 Degrees With SLT?
NCT03529591
Effects of Selective Laser Trabeculoplasty
NCT00986141
Effect of SLT Location on Treatment Outcomes
NCT03164941
Efficacy of Selective Laser Trabeculoplasty Targeting Nasal Versus Inferior 180-degree
NCT06851546
Prospective,Randomized,Controlled Study to Assess Efficacy,Safety, and Tolerability of SLT vs. PLT in Patients With POAG
NCT02231515
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will evaluate the timing (early vs. late completion of SLT therapy) and determined the IOP lowering effect following the interventions.
Arm 1: Early Completion SLT
180 degrees of SLT on Day 1, 180 degrees of SLT on the other 180 degrees on Day 2
Arm 2: Late Completion SLT
180 degrees of SLT on Day 1, 180 degrees of SLT on the other 180 degrees at the 1 month follow up visit.
Primary Outcome: IOP (mmHg).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SLT Early Completion (Arm 1)
Intervention: 180 degrees of laser on Day 1, 180 degrees of laser on the other 180 degree on Day 2
selective laser trabeculoplasty - early completion
180 degrees of laser on day 1 and other 180 degrees on day 2.
SLT Late Completion (Arm 2)
Intervention: 180 degrees of laser on Day 1, 180 degrees of laser on the other 180 degrees at 1 month follow up appointment.
Selective laser trabeculoplasty - late completion
180 degrees of laser on day 1 and other 180 degrees at 1 month follow up point.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
selective laser trabeculoplasty - early completion
180 degrees of laser on day 1 and other 180 degrees on day 2.
Selective laser trabeculoplasty - late completion
180 degrees of laser on day 1 and other 180 degrees at 1 month follow up point.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* primary open angle glaucoma or pseudoexfoliation glaucoma
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Queen's University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Robert Campbell
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert J Campbell, MD
Role: PRINCIPAL_INVESTIGATOR
Queen's University, Kingston, Canada
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hotel Dieu Hospital & Queen's University
Kingston, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Rolim-de-Moura CR, Paranhos A Jr, Loutfi M, Burton D, Wormald R, Evans JR. Laser trabeculoplasty for open-angle glaucoma and ocular hypertension. Cochrane Database Syst Rev. 2022 Aug 9;8(8):CD003919. doi: 10.1002/14651858.CD003919.pub3.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RC-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.